1. Home
  2. KTTA vs MSDL Comparison

KTTA vs MSDL Comparison

Compare KTTA & MSDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTTA
  • MSDL
  • Stock Information
  • Founded
  • KTTA 2020
  • MSDL 2019
  • Country
  • KTTA United States
  • MSDL United States
  • Employees
  • KTTA N/A
  • MSDL N/A
  • Industry
  • KTTA Biotechnology: Pharmaceutical Preparations
  • MSDL
  • Sector
  • KTTA Health Care
  • MSDL
  • Exchange
  • KTTA Nasdaq
  • MSDL NYSE
  • Market Cap
  • KTTA 2.8M
  • MSDL 1.7B
  • IPO Year
  • KTTA 2021
  • MSDL N/A
  • Fundamental
  • Price
  • KTTA $0.72
  • MSDL $19.29
  • Analyst Decision
  • KTTA
  • MSDL Hold
  • Analyst Count
  • KTTA 0
  • MSDL 5
  • Target Price
  • KTTA N/A
  • MSDL $20.00
  • AVG Volume (30 Days)
  • KTTA 192.8K
  • MSDL 419.4K
  • Earning Date
  • KTTA 08-12-2025
  • MSDL 01-01-0001
  • Dividend Yield
  • KTTA N/A
  • MSDL 11.75%
  • EPS Growth
  • KTTA N/A
  • MSDL N/A
  • EPS
  • KTTA N/A
  • MSDL N/A
  • Revenue
  • KTTA N/A
  • MSDL N/A
  • Revenue This Year
  • KTTA N/A
  • MSDL $1,597.39
  • Revenue Next Year
  • KTTA N/A
  • MSDL $15.10
  • P/E Ratio
  • KTTA N/A
  • MSDL N/A
  • Revenue Growth
  • KTTA N/A
  • MSDL N/A
  • 52 Week Low
  • KTTA $0.70
  • MSDL $17.59
  • 52 Week High
  • KTTA $7.50
  • MSDL $23.68
  • Technical
  • Relative Strength Index (RSI)
  • KTTA 33.76
  • MSDL 47.53
  • Support Level
  • KTTA $0.71
  • MSDL $18.85
  • Resistance Level
  • KTTA $0.76
  • MSDL $19.35
  • Average True Range (ATR)
  • KTTA 0.04
  • MSDL 0.27
  • MACD
  • KTTA 0.01
  • MSDL -0.03
  • Stochastic Oscillator
  • KTTA 8.59
  • MSDL 50.28

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

About MSDL MORGAN STANLEY DIRECT LENDING FUND

Morgan Stanley Direct Lending Fund is a fund whose investment objective is to achieve attractive risk-adjusted returns via current income and to a lesser extent, capital appreciation by investing predominantly in directly originated senior secured term loans issued by U.S. middle-market companies backed by private equity sponsors. It invests predominantly in directly originated senior secured term loans including first lien senior secured term loans including unitranche loans and second lien senior secured term loans, with the balance of the investments expected to be in higher-yielding assets such as mezzanine debt, unsecured debt, equity investments and other opportunistic asset purchases.

Share on Social Networks: